Skip to main content
OpenTrials
Completed

NCT Number: NCT00372814

Study of Intensive, Home-Based Family Therapy to Improve Illness Management in Youth With Diabetes

The study is a randomized clinical trial testing the effectiveness of Multisystemic Therapy (MST) for improving the treatment adherence, metabolic control and quality of life of urban adolescents with poorly controlled insulin dependent diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital of Michigan

Detroit, Michigan, 48201, United States

About this study

The deterioration in regimen adherence and metabolic control associated with the adolescent developmental period is well-documented. However, a subset of high-risk adolescents with diabetes demonstrate much more serious adherence problems, as evidenced by chronically poor metabolic control (CPMC) and post-diagnostic admissions for diabetic ketoacidosis (DKA). Adolescents in CPMC represent a group at high risk for both short and long term diabetes complications and are therefore heavy users of medical resources and health care dollars. Minority and low-income children are over-represented among adolescents with CPMC.

The design for the proposed study is a randomized, controlled trial with a repeated measures design using a sample of 170 adolescents, 85 of whom will receive MST and 85 of whom will receive a telephone intervention to test the effect of increased attention (control condition). Subjects must have a current hemoglobin A1C (HbA1c) of >8% and an average HbA1c of >8% during the past year, must be diagnosed with insulin dependent diabetes for at least one year, be 10-17 years of age and reside in the metro Detroit tri-county area. Exclusion criteria are severe mental impairment/thought disorder, non-English speaking patient/parent or a co-morbid major medical condition such as cystic fibrosis. Families who are randomized to MST receive intensive, home-based family therapy for approximately six months. MST is a community based treatment originally designed for use with adolescents presenting with serious mental health problems, but which is adapted in the present study for use with chronically ill youth and serious adherence difficulties. Therapists meet with families two to three times per week at the beginning of treatment with a decreasing number of sessions at the end of treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • insulin dependent Type 1 or Type 2 diabetes
  • diagnosed with diabetes ≥ 1 year
  • current HbA1c ≥ 8%
  • average HbA1c ≥ 8% over the past year
  • aged 10 -17
  • patient of Children's Hospital of Michigan Diabetes Clinic
  • lives within 30 miles of Children's Hospital of Michigan

Exclusion criteria

  • moderate to severe mental retardation (unable to complete study measures)
  • psychosis or current suicidal intent
  • any medical diagnosis that alters standard diabetes care

Treatment and study plan

Intensive Home-Based Family Therapy

Behavioral

Multisystemic Therapy (MST): Adolescents receiving MST will receive home-based, family psychotherapy sessions 2-3 times a week, lasting 60 minutes in duration from a pediatric mental health worker for six months. The purpose of the therapy sessions are to improve the youths' ability to complete their dilay diabetes illness management tasks, reduce average blood glucose levels and improve metabolic control.

Other names: Multisystemic Therapy, MST

Supportive Telephone Calls

Behavioral

Telephone Support Calls: Adolescents receiving TS will receive weekly 30 minute phone calls from a pediatric mental health worker for six months. The purpose of the call is to provide emotional support regarding the adolescent's chronic medical condition, assess adherence to the prescribed regimen and to help the adolescent brainstorm solutions to any barriers they identify to completion of diabetes care.

Other names: TS

Primary outcomes

  1. Metabolic Control: Hemoglobin A1c (HbA1c)

    Time frame: treatment termination, 6-month follow up

    Retrospective measure of blood glucose control, encompasses the previous 2-3 months

Secondary outcomes

  1. BMI percentile

    Time frame: treatment termination, 6-month follow up

    Body mass index (BMI) a value derived from the mass and height of an individual

  2. Diabetes-Specific Family Functioning

    Time frame: treatment termination, 6-month follow up

    Diabetes Family Responsibility Questionnaire (DFRQ), Parental Monitoring of Adolescent Diabetes Care (PMADC), Diabetes Social Support Questionnaire-Family (DSSQ-Family)

  3. DKA admissions and emergency room (ER) Visits: hospital information systems data extraction, Service Utilization Questionnaire (SUQ)

    Time frame: treatment termination, 6-month follow up

    The number of patient visits to acute care settings represents a significant health care cost in this high-risk population.

  4. Regimen Adherence: Diabetes Management Scale (DMS), Twenty-Four Hour Recall Interview, Glucose Meter Downloads

    Time frame: treatment termination, 6-month follow up

    The DMS assesses a broad range of management behaviors, such as insulin management, dietary management, blood glucose monitoring, symptom response, and parent assistance/supervision. Glucose meters only assess blood glucose monitoring, but are empirically linked to metabolic control.

Sponsors and collaborators

Lead sponsor

Wayne State University

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

Adherence to IDDM Regimen in Urban Youth

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Sep 7, 2006
Registry last updated
Jun 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.